Please assess the completion status of the following clinical trial:

Trial Title: Glycemia in Diabetic Elders Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetics diagnosed for at least 6 months~* Patients ages ≥ 65 years and older~* Active patients in the Bay West Endocrinology practice~* Inadequately controlled on oral agents and/or basal insulin with HbA1c between 8.0% and 12%~* Eligible for randomization to either treatment group~* Patients willing to follow either treatment arm including regimen using one or more injectables~* Patients to have an English Reading Level of Grade 6 or above~* Patients residing at home~Exclusion Criteria:~* Unwilling to use a regimen that may contain using one or more injections~* Using short acting insulin prior to the study~* Using GLP-1 in past 10 weeks~* History of hypoglycemia unawareness or episodes needing emergency intervention~* End-stage renal disease~* Dementia~* Blindness~* Terminal illness

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard Treatment (Type: ACTIVE_COMPARATOR): A regimen with traditional drugs only
- Incretin-based Treatment (Type: EXPERIMENTAL): A regimen including incretin-based drugs

Based on this trial design, predict the completion outcome and termination type (if applicable).